Anthem Inc. intends to change its name to Elevance Health Inc., as the company looks to shift its focus beyond the health insurance business.

San Francisco-based biotech company Alumis, formerly Esker Therapeutics, closed on a $200 million Series B financing round.

Compas on July 27 announced a rebranding that reflects future growth of the organization and expansion of its capabilities.

W2O, the healthcare marketing and communications powerhouse founded 20 years ago by Jim Weiss, announced a transformation into a new kind of healthcare company named Real Chemistry.

Cryoport Inc. appointed creative communications agency Mind+Matter, an Ashfield Health company and part of UDG Healthcare, as the company’s strategic marketing partner to support the rebrand of the entire business alongside a strategic communications plan.

WPP’s consumer & HCP performance media powerhouse CMI Media unveiled an extensive rebranding and solution offering in response to vast changes in the healthcare landscape, the agency’s accelerated growth and expanding market possibilities.

Houston-based Cell Medica rebranded as Kuur Therapeutics as the company dives into the development of anti-cancer therapies using an innovative chimeric antigen receptor natural killer T cell (CAR-NKT) therapy platform.

Two years after Cambridge, Mass.-based Akrevia Therapeutics launched, the company rebranded itself as Xilio Therapeutics and secured $100.5 million in a Series B financing round that will be used to advance lead therapeutic candidates into clinical studies.

USRetina, the nation’s largest independent provider of technology and services specific to retina practices, announced the launch of a new corporate brand identity and tagline.

The new global pharmaceutical company combines Mylan N.V. with Upjohn, Pfizer Inc.’s off-patent branded and generic established medicines business.